Top Markets
Coin of the day
BillionToOne, Inc. BillionToOne, Inc.

BillionToOne, Inc.

BLLN
Rankning i aktier #3837
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Aktiekurs
$99.89
Senast synkroniserad: 2026-08-25
Marknadsvärde
$4.59B
Förändring (1 dag)
3.26%
Förändring (1 år)
-
Land
US
Handel BillionToOne, Inc. (BLLN)

Kategori

P/S-tal för BillionToOne, Inc. (BLLN)
P/S-tal per 2026 TTM: 0
Enligt BillionToOne, Inc. senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 0. I slutet av 2026 hade företaget ett P/S-tal på 0.
Historik för P/S-tal för BillionToOne, Inc. från 2026 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
Inte tillräckligt med data för de angivna datumen.
P/S-tal för liknande företag eller konkurrenter